{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:28:31Z","timestamp":1771867711367,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401448"],"award-info":[{"award-number":["82401448"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515110799"],"award-info":[{"award-number":["2021A1515110799"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20240813145414019"],"award-info":[{"award-number":["JCYJ20240813145414019"]}]},{"name":"Shenzhen Nanshan District Science and Technology Plan Funding Program","award":["NSZD2024015"],"award-info":[{"award-number":["NSZD2024015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"DOI":"10.1186\/s12937-025-01198-2","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:19:52Z","timestamp":1755843592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a multimodal model integrating gut microbiota and metabolite for identifying sarcopenia in patients with MASLD: a study from two centers in China"],"prefix":"10.1186","volume":"24","author":[{"given":"Sizhe","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingkai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexiang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuankai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingtian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"6","key":"1198_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"4","key":"1198_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/liv.15852","volume":"44","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Paik J, et al. Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver Int. 2024;44(4):1061\u201370.","journal-title":"Liver Int"},{"issue":"6","key":"1198_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2024.101544","volume":"29","author":"A Malik","year":"2024","unstructured":"Malik A, Javaid S, Malik MI, Qureshi S. Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis. Ann Hepatol. 2024;29(6): 101544.","journal-title":"Ann Hepatol"},{"issue":"9","key":"1198_CR4","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.clnu.2024.07.006","volume":"43","author":"X Li","year":"2024","unstructured":"Li X, He J, Sun Q. The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis. Clin Nutr. 2024;43(9):2005\u201316.","journal-title":"Clin Nutr"},{"issue":"1","key":"1198_CR5","doi-asserted-by":"publisher","first-page":"91100","DOI":"10.4291\/wjgp.v15.i1.91100","volume":"15","author":"S Giri","year":"2024","unstructured":"Giri S, Anirvan P, Angadi S, Singh A, Lavekar A. Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease. World J Gastrointest Pathophysiol. 2024;15(1):91100.","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"6","key":"1198_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.4254\/wjh.v16.i6.871","volume":"16","author":"R Wong","year":"2024","unstructured":"Wong R, Yuan LY. Sarcopenia and metabolic dysfunction associated steatotic liver disease: time to address both. World J Hepatol. 2024;16(6):871\u20137.","journal-title":"World J Hepatol"},{"issue":"3","key":"1198_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/liv.14719","volume":"41","author":"YC Hsieh","year":"2021","unstructured":"Hsieh YC, Joo SK, Koo BK, Lin HC, Kim W. Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2021;41(3):494\u2013504.","journal-title":"Liver Int"},{"issue":"1","key":"1198_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12937-025-01081-0","volume":"24","author":"F Zhang","year":"2025","unstructured":"Zhang F, Liu L, Li W. Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the united States. Nutr J. 2025;24(1):6.","journal-title":"Nutr J"},{"issue":"6","key":"1198_CR9","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1097\/HEP.0000000000000474","volume":"78","author":"RM Carr","year":"2023","unstructured":"Carr RM, Li Y, Chau L, Friedman ES, Lee JJ, Adorini L, Erickson M, Zaru L, Shringarpure R, MacConell L, Bittinger K, Li H, Wu GD. An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations. Hepatology. 2023;78(6):1843\u201357.","journal-title":"Hepatology"},{"key":"1198_CR10","doi-asserted-by":"publisher","first-page":"887728","DOI":"10.3389\/fmicb.2022.887728","volume":"13","author":"AM Yang","year":"2022","unstructured":"Yang AM, Lin CY, Liu SH, Syu GD, Sun HJ, Lee KC, Lin HC, Hou MC. Saccharomyces boulardii ameliorates non-alcoholic steatohepatitis in mice induced by a methionine-choline-deficient diet through gut-liver axis. Front Microbiol. 2022;13:887728.","journal-title":"Front Microbiol"},{"issue":"2","key":"1198_CR11","doi-asserted-by":"publisher","first-page":"e0100623","DOI":"10.1128\/spectrum.01006-23","volume":"12","author":"J Zhang","year":"2024","unstructured":"Zhang J, Shi M, Zhao C, Liang G, Li C, Ge X, Pei C, Kong Y, Li D, Yang W, Cao B, Fu L, Yan Y, Wu J, Zhou J, Fang Y, Meng X, Li Y, Wang L. Role of intestinal flora in the development of nonalcoholic fatty liver disease in children. Microbiol Spectr. 2024;12(2):e0100623.","journal-title":"Microbiol Spectr"},{"issue":"5","key":"1198_CR12","volume":"12","author":"S Pezzino","year":"2023","unstructured":"Pezzino S, Sofia M, Mazzone C, Castorina S, Puleo S, Barchitta M, Agodi A, Gallo L, La Greca G, Latteri S. Gut microbiome in the progression of NAFLD, NASH and cirrhosis, and its connection with biotics: a bibliometric study using dimensions scientific research database. Biology (Basel). 2023;12(5): 662.","journal-title":"Biology (Basel)"},{"issue":"5","key":"1198_CR13","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1002\/jcsm.13037","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Y, Lane NE, et al. Population-based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya sarcopenia study. J Cachexia Sarcopenia Muscle. 2022;13(5):2340\u201351.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"1198_CR14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/nu15051266","volume":"15","author":"Z Wang","year":"2023","unstructured":"Wang Z, Xu X, Deji Y, et al. Bifidobacterium as a potential biomarker of sarcopenia in elderly women. Nutrients. 2023;15(5):1266.","journal-title":"Nutrients"},{"key":"1198_CR15","doi-asserted-by":"publisher","first-page":"1127041","DOI":"10.3389\/fcimb.2023.1127041","volume":"13","author":"J Peng","year":"2023","unstructured":"Peng J, Gong H, Lyu X, et al. Characteristics of the fecal microbiome and metabolome in older patients with heart failure and sarcopenia. Front Cell Infect Microbiol. 2023;13:1127041.","journal-title":"Front Cell Infect Microbiol"},{"key":"1198_CR16","doi-asserted-by":"publisher","first-page":"1279448","DOI":"10.3389\/fphar.2023.1279448","volume":"14","author":"J Zhou","year":"2023","unstructured":"Zhou J, Liu J, Lin Q, et al. Characteristics of the gut microbiome and metabolic profile in elderly patients with sarcopenia. Front Pharmacol. 2023;14:1279448.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1198_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2024;29(1): 101133.","journal-title":"Ann Hepatol"},{"issue":"2","key":"1198_CR18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu L, Baker SS, Gill C, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013;57(2):601\u20139.","journal-title":"Hepatology"},{"issue":"8","key":"1198_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081089","volume":"8","author":"HN Kim","year":"2019","unstructured":"Kim HN, Joo EJ, Cheong HS, et al. Gut microbiota and risk of persistent nonalcoholic fatty liver diseases. J Clin Med. 2019;8(8): 1089.","journal-title":"J Clin Med"},{"issue":"1","key":"1198_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hep.26319","volume":"58","author":"M Mouzaki","year":"2013","unstructured":"Mouzaki M, Comelli EM, Arendt BM, et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology. 2013;58(1):120\u20137.","journal-title":"Hepatology"},{"issue":"7415","key":"1198_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220\u201330.","journal-title":"Nature"},{"issue":"6","key":"1198_CR22","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1053\/j.gastro.2010.08.049","volume":"139","author":"BP Willing","year":"2010","unstructured":"Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that Gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139(6):1844\u2013e18541.","journal-title":"Gastroenterology"},{"issue":"3","key":"1198_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1086\/525047","volume":"197","author":"JY Chang","year":"2008","unstructured":"Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent clostridium difficile-associated diarrhea. J Infect Dis. 2008;197(3):435\u20138. https:\/\/doi.org\/10.1086\/525047.","journal-title":"J Infect Dis"},{"issue":"7464","key":"1198_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature12506","volume":"500","author":"E Le Chatelier","year":"2013","unstructured":"Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541\u20136.","journal-title":"Nature"},{"issue":"Suppl 2","key":"1198_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s12072-024-10661-x","volume":"18","author":"WK Chan","year":"2024","unstructured":"Chan WK, Wong VW, Adams LA, Nguyen MH. Mafld in adults: non-invasive tests for diagnosis and monitoring of MAFLD. Hepatol Int. 2024;18(Suppl 2):909\u201321.","journal-title":"Hepatol Int"},{"issue":"7","key":"1198_CR26","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1136\/gutjnl-2019-319114","volume":"69","author":"LH Quan","year":"2020","unstructured":"Quan LH, Zhang C, Dong M, et al. Myristoleic acid produced by enterococci reduces obesity through brown adipose tissue activation. Gut. 2020;69(7):1239\u201347.","journal-title":"Gut"},{"issue":"4","key":"1198_CR27","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/liv.14377","volume":"40","author":"S Lang","year":"2020","unstructured":"Lang S, Demir M, Duan Y, Martin A, Schnabl B. Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis. Liver Int. 2020;40(4):860\u20135.","journal-title":"Liver Int"},{"issue":"3","key":"1198_CR28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/nu13031013","volume":"13","author":"JH Oh","year":"2021","unstructured":"Oh JH, Lee JH, Cho MS, et al. Characterization of gut microbiome in Korean patients with metabolic associated fatty liver disease. Nutrients. 2021;13(3):1013.","journal-title":"Nutrients"},{"issue":"20","key":"1198_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015272","volume":"24","author":"AV Korobeinikova","year":"2023","unstructured":"Korobeinikova AV, Zlobovskaya OA, Sheptulina AF, et al. Gut microbiota patterns in patients with non-alcoholic fatty liver disease: a comprehensive assessment using three analysis methods. Int J Mol Sci. 2023;24(20): 15272.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1198_CR30","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41467-023-37055-1","volume":"14","author":"K Brown","year":"2023","unstructured":"Brown K, Thomson CA, Wacker S, et al. Microbiota alters the metabolome in an age- and sex- dependent manner in mice. Nat Commun. 2023;14(1):1348.","journal-title":"Nat Commun"},{"issue":"1","key":"1198_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41467-023-35861-1","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Qi X, Li N, et al. Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol. Nat Commun. 2023;14(1):228.","journal-title":"Nat Commun"},{"issue":"33","key":"1198_CR32","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1073\/pnas.1005963107","volume":"107","author":"C De Filippo","year":"2010","unstructured":"De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107(33):14691\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1198_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2351620","volume":"16","author":"J Wei","year":"2024","unstructured":"Wei J, Luo J, Yang F, et al. Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine. Gut Microbes. 2024;16(1): 2351620.","journal-title":"Gut Microbes"},{"issue":"1","key":"1198_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41564-022-01273-y","volume":"8","author":"RO Ali","year":"2023","unstructured":"Ali RO, Quinn GM, Umarova R, et al. Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis. Nat Microbiol. 2023;8(1):12\u201327.","journal-title":"Nat Microbiol"},{"issue":"1","key":"1198_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2423040","volume":"16","author":"X Wen","year":"2024","unstructured":"Wen X, Feng X, Xin F, et al. B. vulgatus ameliorates high-fat diet-induced obesity through modulating intestinal serotonin synthesis and lipid absorption in mice. Gut Microbes. 2024;16(1): 2423040.","journal-title":"Gut Microbes"},{"issue":"8","key":"1198_CR36","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","volume":"50","author":"PB Hylemon","year":"2009","unstructured":"Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, Dent P. Bile acids as regulatory molecules. J Lipid Res. 2009;50(8):1509\u201320.","journal-title":"J Lipid Res"},{"issue":"11","key":"1198_CR37","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/ajcn\/27.11.1341","volume":"27","author":"T Midtvedt","year":"1974","unstructured":"Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr. 1974;27(11):1341\u20137.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1198_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051214","volume":"20","author":"H Zeng","year":"2019","unstructured":"Zeng H, Umar S, Rust B, Lazarova D, Bordonaro M. Secondary bile acids and short chain fatty acids in the colon: A focus on colonic microbiome, cell proliferation, inflammation, and cancer. Int J Mol Sci. 2019;20(5): 1214.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1198_CR39","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","volume":"49","author":"L Miele","year":"2009","unstructured":"Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49(6):1877\u201387.","journal-title":"Hepatology"},{"issue":"6","key":"1198_CR40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.dld.2014.02.010","volume":"46","author":"V Giorgio","year":"2014","unstructured":"Giorgio V, Miele L, Principessa L, et al. Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity. Dig Liver Dis. 2014;46(6):556\u201360.","journal-title":"Dig Liver Dis"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12937-025-01198-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:18:18Z","timestamp":1757445498000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-025-01198-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1198"],"URL":"https:\/\/doi.org\/10.1186\/s12937-025-01198-2","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the Third Affiliated Hospital of Sun Yat-sen University (Approval Number: [2019]02\u2009\u2212\u2009530\u2009\u2212\u200901) and the Shenzhen Hospital of Southern Medical University (Approval Number: NYSZYYEC20190017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}